Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1089

1.

Pathologically and biologically distinct types of epithelium in intraductal papillary mucinous neoplasms: delineation of an "intestinal" pathway of carcinogenesis in the pancreas.

Adsay NV, Merati K, Basturk O, Iacobuzio-Donahue C, Levi E, Cheng JD, Sarkar FH, Hruban RH, Klimstra DS.

Am J Surg Pathol. 2004 Jul;28(7):839-48.

PMID:
15223952
[PubMed - indexed for MEDLINE]
2.

Intraductal papillary-mucinous neoplasms of the pancreas: an analysis of in situ and invasive carcinomas in 28 patients.

Adsay NV, Conlon KC, Zee SY, Brennan MF, Klimstra DS.

Cancer. 2002 Jan 1;94(1):62-77.

PMID:
11815961
[PubMed - indexed for MEDLINE]
Free Article
3.

The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas: differential expression of MUC1 and MUC2 supports the existence of two separate pathways of carcinogenesis.

Adsay NV, Merati K, Andea A, Sarkar F, Hruban RH, Wilentz RE, Goggins M, Iocobuzio-Donahue C, Longnecker DS, Klimstra DS.

Mod Pathol. 2002 Oct;15(10):1087-95.

PMID:
12379756
[PubMed - indexed for MEDLINE]
Free Article
4.

Intraductal papillary mucinous neoplasm (IPMN) of the pancreas: its histopathologic difference between 2 major types.

Ban S, Naitoh Y, Mino-Kenudson M, Sakurai T, Kuroda M, Koyama I, Lauwers GY, Shimizu M.

Am J Surg Pathol. 2006 Dec;30(12):1561-9.

PMID:
17122512
[PubMed - indexed for MEDLINE]
5.

REG4 is associated with carcinogenesis in the 'intestinal' pathway of intraductal papillary mucinous neoplasms.

Nakata K, Nagai E, Ohuchida K, Aishima S, Hayashi A, Miyasaka Y, Yu J, Mizumoto K, Tanaka M, Tsuneyoshi M.

Mod Pathol. 2009 Mar;22(3):460-8. doi: 10.1038/modpathol.2008.205. Epub 2009 Jan 9.

PMID:
19136934
[PubMed - indexed for MEDLINE]
Free Article
7.

Preferential expression of MUC6 in oncocytic and pancreatobiliary types of intraductal papillary neoplasms highlights a pyloropancreatic pathway, distinct from the intestinal pathway, in pancreatic carcinogenesis.

Basturk O, Khayyata S, Klimstra DS, Hruban RH, Zamboni G, Coban I, Adsay NV.

Am J Surg Pathol. 2010 Mar;34(3):364-70. doi: 10.1097/PAS.0b013e3181cf8bb6.

PMID:
20139757
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Mucin gene expression in intraductal papillary-mucinous pancreatic tumours and related lesions.

Terris B, Dubois S, Buisine MP, Sauvanet A, Ruszniewski P, Aubert JP, Porchet N, Couvelard A, Degott C, Fléjou JF.

J Pathol. 2002 Aug;197(5):632-7.

PMID:
12210083
[PubMed - indexed for MEDLINE]
9.

Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of Vater adenocarcinoma: application of CDX2, CK17, MUC1, and MUC2.

Chu PG, Schwarz RE, Lau SK, Yen Y, Weiss LM.

Am J Surg Pathol. 2005 Mar;29(3):359-67.

PMID:
15725805
[PubMed - indexed for MEDLINE]
10.

New classification of pancreatic intraductal papillary-mucinous tumour by mucin expression: its relationship with potential for malignancy.

Nakamura A, Horinouchi M, Goto M, Nagata K, Sakoda K, Takao S, Imai K, Kim YS, Sato E, Yonezawa S.

J Pathol. 2002 Jun;197(2):201-10.

PMID:
12015744
[PubMed - indexed for MEDLINE]
11.

Comparison of histologic subtype and growth pattern in intraductal papillary-mucinous carcinoma of the pancreas.

Sanada Y, Kunita S, Yoshida K.

Oncol Rep. 2008 Jun;19(6):1435-43.

PMID:
18497948
[PubMed - indexed for MEDLINE]
12.

Intraductal papillary mucinous neoplasm of the pancreas: cytologic features predict histologic grade.

Michaels PJ, Brachtel EF, Bounds BC, Brugge WR, Pitman MB.

Cancer. 2006 Jun 25;108(3):163-73.

PMID:
16550572
[PubMed - indexed for MEDLINE]
Free Article
13.
14.

The expression of several types of mucin is related to the biological behavior of pancreatic neoplasms.

Yonezawa S, Nakamura A, Horinouchi M, Sato E.

J Hepatobiliary Pancreat Surg. 2002;9(3):328-41.

PMID:
12353144
[PubMed - indexed for MEDLINE]
15.

Intraductal papillary mucinous neoplasms of the pancreas with distinct pancreatic ductal adenocarcinomas are frequently of gastric subtype.

Ideno N, Ohtsuka T, Kono H, Fujiwara K, Oda Y, Aishima S, Ito T, Ishigami K, Tokunaga S, Ohuchida K, Takahata S, Nakamura M, Mizumoto K, Tanaka M.

Ann Surg. 2013 Jul;258(1):141-51. doi: 10.1097/SLA.0b013e31828cd008.

PMID:
23532108
[PubMed - indexed for MEDLINE]
16.

Aberrant expression of CDX2 is closely related to the intestinal metaplasia and MUC2 expression in intraductal papillary neoplasm of the liver in hepatolithiasis.

Ishikawa A, Sasaki M, Ohira S, Ohta T, Oda K, Nimura Y, Chen MF, Jan YY, Yeh TS, Nakanuma Y.

Lab Invest. 2004 May;84(5):629-38.

PMID:
15048136
[PubMed - indexed for MEDLINE]
Free Article
17.

Biliary intraductal papillary mucinous neoplasia: three case reports.

Yaman B, Nart D, Yilmaz F, Coker A, Zeytunlu M, Kilic M.

Virchows Arch. 2009 May;454(5):589-94. doi: 10.1007/s00428-009-0767-1. Epub 2009 Apr 4.

PMID:
19347361
[PubMed - indexed for MEDLINE]
18.

Significance of mucin expression in pancreatobiliary neoplasms.

Yonezawa S, Higashi M, Yamada N, Yokoyama S, Goto M.

J Hepatobiliary Pancreat Sci. 2010 Mar;17(2):108-24. doi: 10.1007/s00534-009-0174-7. Epub 2009 Sep 29. Review.

PMID:
19787286
[PubMed - indexed for MEDLINE]
19.

[Diagnosis and differential diagnosis of intraductal papillary mucinous neoplasm of pancreas].

Ji Y, Tan YS, Zhu XZ, Zeng HY, Kuang TT, Jin DY.

Zhonghua Bing Li Xue Za Zhi. 2006 Feb;35(2):77-81. Chinese.

PMID:
16630480
[PubMed - indexed for MEDLINE]
20.

MUC1 overexpression is the most reliable marker of invasive carcinoma in intraductal papillary-mucinous tumor (IPMT).

Ueda M, Miura Y, Kunihiro O, Ishikawa T, Ichikawa Y, Endo I, Sekido H, Togo S, Shimada H.

Hepatogastroenterology. 2005 Mar-Apr;52(62):398-403.

PMID:
15816444
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk